Immunogenicity and Tolerability of Recombinant Serogroup B Meningococcal Vaccine Administered With or Wtihout Routine Infant Vaccinations According to Different Immunization Schedules A Randomized Controlled Trial
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F12%3A10130664" target="_blank" >RIV/00179906:_____/12:10130664 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Immunogenicity and Tolerability of Recombinant Serogroup B Meningococcal Vaccine Administered With or Wtihout Routine Infant Vaccinations According to Different Immunization Schedules A Randomized Controlled Trial
Original language description
Meningococcal disease occurs with an incidence of 0,2 to 14 per 100 000 population in industrialized countries. Effective vaccines based on capsular polysaccharides for meningococcal serogroups A, C, W-135, and Y are available, but serogroup B capsular polysaccharide is antigenically similar to human neurol cell glycopeptides containig polysialic acid and poorly immunogenic in humans.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
EC - Immunology
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2012
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of the American Medical Association
ISSN
0098-7484
e-ISSN
—
Volume of the periodical
307
Issue of the periodical within the volume
6
Country of publishing house
US - UNITED STATES
Number of pages
10
Pages from-to
573-582
UT code for WoS article
000299992500021
EID of the result in the Scopus database
—